| Active ingredient (INN) | Linezolid |
|---|---|
| Brand names | LINEVOX linezolid |
| ATC level 5 | J01XX08 |
| ATC level 4 | J01XX |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Pharmacor Pty Ltd, Pfizer Limited, KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO, FRESENIUS KABI LIMITED +4 more |
| Registrations on file | 15 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Akm | 600 mg | — | 🇦🇺 AU | Pharmacor Pty Ltd | Active |
| Pharmacor | 600 mg | — | 🇦🇺 AU | Pharmacor Pty Ltd | Active |
| Rjic | 600mg | — | 🇦🇺 AU | — | Active |
| Dwrn | 600mg | — | 🇦🇺 AU | — | Active |
| LINEZOLID 2 MG/ML SOLUTION FOR INFUSION | 2 MG | solution | 🇬🇧 GB | Pfizer Limited | Active |
| LINEZOLID 600 MG FILM-COATED TABLETS | 600 MG | tablet | 🇬🇧 GB | Pfizer Limited | Active |
| Linezolid Krka | 600 MG | tablet | 🇬🇧 GB | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO | Active |
| LINEZOLID 2MG/ML SOLUTION FOR INFUSION | 2MG | solution | 🇬🇧 GB | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO | Active |
| LINEZOLID 2 MG/ ML SOLUTION FOR INFUSION | 2 MG | solution | 🇬🇧 GB | FRESENIUS KABI LIMITED | Active |
| Cip | 600 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Ca | 600 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Cipla | 600 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| LINEZOLID 600MG FILM COATED TABLETS | 600MG | tablet | 🇬🇧 GB | BRISTOL LABORATORIES LIMITED | Active |
| LINEZOLID 600MG FILM-COATED TABLETS | 600MG | tablet | 🇬🇧 GB | CRESCENT PHARMA LIMITED | Active |
| Linezolid | 100mg/5mL | suspension | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |